Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T04:26:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has been updated to version v2.11.0, while a notice regarding delays in displaying study record information has been removed.
    Difference
    4%
    Check dated 2024-09-25T21:59:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, with the latest update being version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:15:56.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T02:48:55.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    New content was added on August 26, 2024, while previous content was removed on June 11, 2024.
    Difference
    0.6%
    Check dated 2024-08-28T01:47:57.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T21:38:41.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.